Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): Comparison of indolent and progressive disease

By Kiaii Shahryar   Choudhury Aniruddha   Mozaffari Fariba   Kimby Eva   Österborg Anders   Mellstedt Håkan  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 291-302

Humana Press, Inc

Access to resources Recommend Favorite

Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia

By Lundin Jeanette   Karlsson Claes   Celsing Fredrik  

Medical Oncology, Vol. 23, Iss. 1, 2006-03 ,pp. : 137-139

Humana Press, Inc

Access to resources Recommend Favorite

Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-CELL chronic lymphocytic leukemia

By Cavalli-Björkman Nina   Ösby Eva   Lundin Jeanette   Kalin Mats   Österborg Anders   Gruber Astrid  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 277-280

Humana Press, Inc

Access to resources Recommend Favorite

B-cell receptor signaling in chronic lymphocytic leukemia leans on Lyn

By Herishanu Yair  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1125-1126

Informa Healthcare

Access to resources Recommend Favorite

Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia

By Hebenstreit Karin   Iacobelli Simona   Leiblein Sabine   Eisfeld Ann-Kathrin   Pfrepper Christian   Heyn Simone   Vucinic Vladan   Franke Georg-Nikolaus   Krahl Rainer   Fricke Stephan   Becker Cornelia   Pönisch Wolfram   Behre Gerhard   Niederwieser Dietger   Lange Thoralf  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1274-1280

Informa Healthcare

Access to resources Recommend Favorite